Poseida Therapeutics Announces Research Collaboration with Takeda for Novel Non-Viral In Vivo Gene Therapies by Seini Moimoi | Oct 12, 2021 | Portfolio News
Theseus Pharmaceuticals Announces Pricing of Initial Public Offering by Seini Moimoi | Oct 6, 2021 | Portfolio News
Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc. by Seini Moimoi | Oct 5, 2021 | Portfolio News
Rapid Micro Biosystems Announces Appointment of Andy Keys as Chief Commercial Officer by Seini Moimoi | Oct 5, 2021 | Portfolio News
Nabriva Publishes Data Demonstrating the Potent Anti-Inflammatory Properties of XENLETA® (lefamulin) by Seini Moimoi | Oct 4, 2021 | Portfolio News
